Anne Moore

4.8k citations

30 papers · 1.2k indexed · h-index 14

Impact in

Oncology top 5%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cancer survivorship and care
- Neutropenia and Cancer Infections
Cancer Research top 5%
- Breast Cancer Treatment Studies

Papers in

Cancer Research 11
- Cancer, Hypoxia, and Metabolism 5
- Breast Cancer Treatment Studies 5
Urology 3
- Hair Growth and Disorders 3

Co-authors: Linda T. Vahdat John Ellerton Carolyn Ferree Larry Norton Ronald D. Hart W. C. Wood Tessa Cigler Ellen Chuang
Journals: Journal of Clinical Oncology (5 papers)Breast Cancer Research and Treatment (3 papers)Cancer Research (3 papers)Cancer (1 paper)British Journal of Haematology (1 paper)
Partner nations: United States Denmark Canada

In The Last Decade

Anne Moore

29 papers receiving 1.2k citations

Peers

Countries citing papers authored by Anne Moore

Since Specialization

Citations

This map shows the geographic impact of Anne Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Moore more than expected).

Fields of papers citing papers by Anne Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Moore. The network helps show where Anne Moore may publish in the future.

Co-authors

The 25 scholars most cited alongside Anne Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anne Moore Line = papers co-authored together Anne Moore links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Impact of HER2 low expression in the Oncotype DX RS in patients with operable hormone receptor positive early stage breast cancer. Journal of Clinical Oncology ·梁宏伟, Eleonora Nicolò, Lisa A. Newman, Tessa Cigler, Eleni Andreopoulou, Anne Moore, V.S. Srivishnu, Massimo Cristofanilli	2023	1
2	Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer Breast Cancer Research and Treatment ·Abdul Azis Akbar, Liang Gao, Yalei Chen, Leticia Varella, Tessa Cigler, Jessica Bensenhaver, Rache M. Simmons, Alexander Swistel, Jennifer L. Marti, Anne Moore, Eleni Andreopoulou, John Ng, Andrew Brandmaier, Silvia C. Formenti, Haythem Ali, Melissa B. Davis, Lisa A. Newman	2022	10
3	Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer npj Breast Cancer ·Ying L. Liu, Cecilie L. Bager, Nicholas Willumsen, Divya Ramchandani, Naomi Kornhauser, Ling Lu, Marta Vallee Cobham, Eleni Andreopoulou, Tessa Cigler, Anne Moore, دهقاني أيوب, Veronica Fitzpatrick, Maureen M. Ward, J. David Warren, Claudia Fischbach, Vivek Mittal, Linda T. Vahdat	2021	58
4	Preoperative Risk Factor Optimization Lowers Hospital Length of Stay and Postoperative Emergency Department Visits in Primary Total Hip and Knee Arthroplasty Patients The Journal of Arthroplasty ·Chloe C. Dlott, Anne Moore, Muthu Gopalakrishnan Mariyappa, Pracha Rd, Mateusz Przybyła, Davor Žiška, Nan Zheng, Lee E. Rubin, Mary I. O’Connor	2020	53
5	Telerehabilitation for Total Hip and Knee Arthroplasty Patients: A Pilot Series with High Patient Satisfaction HSS Journal® The Musculoskeletal Journal of Hospital for Special Surgery ·Mubin Hossain Omio, Anne Moore, Joseph B. Kahan, Shuzhao Chen, 方磊, Tedlapu Narayana Rao, Isabelle Brännlund, Otara Schalwowischa Gogniashvili, Bohdanna T. Zazulak, Lee E. Rubin, Mary I. O’Connor	2019	34
6	Stress and Response to Treatment: Insights From a Pilot Study Using a 4-week Contemplative Self-Healing Meditation Intervention for Posttraumatic Stress in Breast Cancer Journal of Evidence-Based Complementary & Alternative Medicine ·Emanuela Offidani, Janey C. Peterson, C. E. Frasier, Anne Moore, Mary E. Charlson	2017	13
7	Abstract LB-349: Copper depletion as a strategy to affect the tumor microenvironment in breast cancer patients at high risk of relapse and in triple negative preclinical models of breast cancer: Updated results of a phase II study of tetrathiomolybdate (TM) in breast cancer (BC) patients (pts) at high risk for recurrence Cancer Research ·Eleni Nackos, Sharrell Lee, Amy D. Willis, Naomi Kornhauser, Maureen M. Ward, Marta Vallee Cobham, Tessa Cigler, Anne Moore, Veronica Fitzpatrick, Sarah Schneider, Hazel Snell Schreiber, L. Liu, Bo Ri Seo, J. David Warren, J B Kortright, Claudia Fischbach, Vivek Mittal, Linda T. Vahdat	2016	1
8	Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity BMC Cancer ·Sasha E. Stanton, Maureen M. Ward, Paul J. Christos, Rachel Sanford, Arisa Jinno, Marta Vallee Cobham, Diana Donovan, Ronald Scheff, Tessa Cigler, Anne Moore, Linda T. Vahdat, Maureen E. Lane, Ellen Chuang	2015	56
9	Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy Clinical Breast Cancer ·Tessa Cigler, 武志前田, Kimberly Ann Chernesky, Sarah Schneider, Ellen Chuang, Linda T. Vahdat, Anne Moore	2015	38
10	Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse Annals of Oncology ·Sarika Jain, Jules Cohen, Maureen M. Ward, Naomi Kornhauser, Ellen Chuang, Tessa Cigler, Anne Moore, Diana Donovan, Alexey Shikhovets, Rashidat Olayokun, Sarah Schneider, Sandra Hurtado Rúa, Valentino Pistone, Fengzhou CHENG, 김민권, J. David Warren, Maureen E. Lane, Vivek Mittal, Shahin Rafii, Linda T. Vahdat	2013	79
11	Patient perspectives on breast cancer treatment plan and summary documents in community oncology care Cancer ·Victoria Blinder, Virginia W. Norris, N. W. Peacock, Jennifer J. Griggs, David P. Harrington, Anne Moore, Richard L. Theriault, Ann H. Partridge	2012	42
12	Breast Cancer Subtypes in Asian-Americans Differ According to Asian Ethnic Group Journal of Immigrant and Minority Health ·Ellen Chuang, Paul J. Christos, Alejandro Cataldo Cornejo, Joanne Staudt, Melissa Forst, Sandra J. Shin, Linda T. Vahdat, Alexander Swistel, Rache M. Simmons, Michael P. Osborne, Anne Moore, Madhu Mazumdar, Paula Klein	2012	26
13	Incremental increase in VEGFR1+ hematopoietic progenitor cells and VEGFR2+ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients Breast Cancer Research and Treatment ·Sarika Jain, Maureen M. Ward, Jennifer O’Loughlin, Marissa A. Boeck, L. Gevlych, Ellen Chuang, Tessa Cigler, Anne Moore, Diana Donovan, Arisa Jinno, Marta Vallee Cobham, Sarah Schneider, Paul J. Christos, Rebecca N. Baergen, Alexander Swistel, Maureen E. Lane, Vivek Mittal, Shahin Rafii, Linda T. Vahdat	2011	27
14	Employment After a Breast Cancer Diagnosis: A Qualitative Study of Ethnically Diverse Urban Women Journal of Community Health ·Victoria Blinder, Madhuvanti M. Murphy, Linda T. Vahdat, Heather T. Gold, Inmaculada de Melo‐Martín, M Hoebeke, Ronald Scheff, Ellen Chuang, Anne Moore, Madhu Mazumdar	2011	55
15	Breast-Cancer Therapy — Looking Back to the Future Apollo Medicine ·Anne Moore	2008	3
16	Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer Breast Cancer Research and Treatment ·Rakhi P. Naik, David Jin, Ellen Chuang, M. Masso-Reid, Eleni A. Tousimis, Anne Moore, Paul J. Christos, امیرصمد قدس, Diana Donovan, Shahin Rafii, Linda T. Vahdat	2007	81
17	Determination of Size in Invasive Breast Carcinoma PubMed ·Sandra J. Shin, Michael P. Osborne, Anne Moore, Mary K. Hayes, Syed A. Hoda	2000	3
18	Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma New England Journal of Medicine ·W. C. Wood, (unknown), (unknown), (unknown), (unknown), Ronald D. Hart, Anne Moore, John Ellerton, Larry Norton, Carolyn Ferree, (unknown), (unknown), (unknown)	1994	455
19	Amplified Lymphokine Production Phenomenon Confirmed by a Macrophage 2- d -[ ³ H]Deoxyglucose Transport Assay Infection and Immunity ·J. G. McCormack, Anne Moore, Phuong Huynh, V. I. Eliseev	1981	6
20	Myosin in Cultured Human Endothelial Cells British Journal of Haematology ·Anne Moore, Chen Hong-le, Carl G. Becker, Ralph L. Nachman	1977	7

About Anne Moore

Anne Moore is a scholar working on Cancer Research, Urology, Oncology, Dermatology and Internal Medicine, having authored 30 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (5 papers), Breast Cancer Treatment Studies (5 papers), Angiogenesis and VEGF in Cancer (5 papers), Hair Growth and Disorders (3 papers), Global Cancer Incidence and Screening (3 papers), Cancer survivorship and care (3 papers), Inflammatory mediators and NSAID effects (3 papers) and Chemotherapy-related skin toxicity (3 papers). The work is most often cited by research in Oncology (770 citations), Cancer Research (399 citations), Urology (108 citations), Dermatology (132 citations) and Pathology and Forensic Medicine (111 citations). Anne Moore has collaborated with scholars based in United States, Denmark and Canada. Frequent co-authors include Linda T. Vahdat, John Ellerton, Carolyn Ferree, Larry Norton, Ronald D. Hart, W. C. Wood, Tessa Cigler, Ellen Chuang, Diana Donovan and Maureen M. Ward. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancer Research, Cancer and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact